News

The FDA accepted the filing the Sanofi’s new drug application for rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers.

Zomig (zolmitriptan) nasal spray 5mg achieved a 58.1% headache response rate in adolescents compared to a 43.3% response in those treated with placebo after one hour, a 14.8%

This phase I study includes 290 volunteers and is being conducted at BioSciences Laboratories in Montana to investigate the effectiveness of Microcyn Technology. Initial results are expected by

The antibody-drug, originally licensed from Seattle Genetics by Protein is directed against the PR1 antigen, which is frequently differentially expressed in prostrate cancer patients. Protein will receive an

The plant, based in Ireland and costing $90 million, has just produced its first batch of drugs aimed at reducing the risk of heart disease. The facility will

The partnership has been created through a subsidiary company of Generex, Antigen Express, who discovered the mechanisms of the so called “Li” protein which is to be the

The studies conducted in collaboration with Reproductive Biology Associates, a US IVF clinic, show that eggs treated with Cumulase prior in vitro fertilization (IVF) using the intracytoplasmic sperm

The preclinical data based on animal models of two different viruses showed that Tarvacin binds to enveloped virus particles representing six different virus families including HIV 1 and

The FDA grants priority review to products that could potentially offer a significant improvement compared to marketed products in the treatment, diagnosis or prevention of a disease. A